[1] Seijo LM, Peled N, Ajona D, et al. Biomarkers in lung cancer screening: achievements, promises, and challenges[J]. J Thorac Oncol,2019,14(3):343-357.
[2] Wang J, Jia Y, Zhao S, et al. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in nonsmall cell lung cancer[J]. Oncogene,2017,36(45):6235-6243.
[3] Garzon R, Calin GA, Croce CM. MicroRNAs in cancer[J]. Annu Rev Med,2009,60(1):167-179.
[4] Fan BL,Ji XH,Zhu WL. Effects of miR-100 on mitotic arrest and Polo-like kinase 1 protein expression in hepatocellular carcinoma cells[J]. Acta Acatomica Sinica,2014,45(1):70-73 (in Chinese)
范秉琳,嵇晓辉,朱武凌. MiR-100对肝癌细胞有丝分裂阻滞及Polo样激酶1蛋白表达的作用[J]. 解剖学报,2014,45(1):70-73.
[5] Raponi M, Dossey L, Jatkoe T, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer[J]. Cancer Res,2009,69(14):5776-5783.
[6] Kumar MS, Erkeland S , Pester RE, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family[J]. Proc Natl Acad Sci USA,2008,105(10):3903-3908.
[7] Phan NN, Wang CY, Li KL, et al. Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient[J]. Oncotarget,2018,9(6):6977-6992.
[8] Chang JL, Chen TH, Wang CF, et al. Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer[J]. Exp Cell Res,2006,312(7):962-973.
[9] Hayama S, Daigo Y, Yamabuki T, et al. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis[J]. Cancer Res,2007,67(9):4113-4122.
[10] Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung[J]. Proc Natl Acad Sci USA,2001,98(24):13784-13789.
[11] Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival[J]. PLoS One,2008,3(2):e1651.
[12] Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction[J]. PLoS One,2010,5(4): e10312.
[13] Selamat SA, Chung BS, Girard L, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression[J]. Genome Res,2012,22(7):1197-1211.
[14] Okayama H, Kohno T, Ishii Y, et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas[J]. Cancer Res,2012,72(1):100-111.
[15] Zhang GX,Xu XW,Meng B,et al. MiR-186-5p inhibits epithelial mesenchymal transition in lung adenocarcinoma cells through modulating PTTG1[J]. Chinese Journal of Biochemistry and Molecular Biology, 2017, 33(4): 380-385 (in Chinese)
张国新,徐新伟,孟斌,等. MiR-186-5p通过靶向调控PTTG1抑制肺腺癌细胞的上皮-间质转化[J]. 中国生物化学与分子生物学报,2017,33(4):380-385.
[16] Zhang B, Li H, Yin C, et al. Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31[J]. Neuropathol Appl Neurobiol,2017,43(5):419-432.
[17] Yin C, Mou Q, Pan X, et al. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25[J]. Thorac Cancer,2018,9(4):472-479.
[18] Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation[J]. Science,2007,318(5858):1931-1934.
[19] Kai Y, Peng W, Ling W, et al. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells[J]. Biochem Biophys Res Commun,2014,448(3):308-314.
[20] Yuan Y, Shen Y, Xue L, et al. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor[J]. PLoS one,2013,8(9):e73604.
[21] Ma J, Zhang F, Sun P. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis[J]. Bioorg Med Chem,2020,28(3):115283.
[22] Zhou Y, Wang B, Wang Y, et al. miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28[J]. Oncol Lett,2019,17(4):3835-3841.
[23] Dong W, Yao C, Teng X, et al. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer[J]. Tumour Biol,2016,37(3):2973-2985.
[24] Liu ZhJ, Dou LT, Zhuang Zh, et al. Screening and survival analysis of differentially expressed genes in papillary thyroid carcinoma[J]. Acta Anatomica Sinica, 2020,51(1),51-57. (in Chinese)
刘中娇,窦龙涛,庄振,等. 乳头状甲状腺癌差异表达基因的筛选及生存分析[J]. 解剖学报,2020,51(1):51-57.
[25] Kong X, Zhang G, Huo Y, et al. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2[J]. Int J Clin Exp Pathol,2015,8(10):12845.
[26] Ci C, Tang B, Lyu D, et al. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis[J]. Int Jo Mol Med,2019,43(1):404-412.
[27] Wang Y, Zhao Z, Bao X, et al. Borealin/Dasra B is overexpressed in colorectal cancers and contributes to proliferation of cancer cells[J]. Med Oncol,2014,31(11):248.
[28] Bi Y, Chen S, Jiang J, et al. CDCA8 expression and its clinical relevance in patients with bladder cancer[J]. Medicine,2018,97(34): e11899.
|